TCTMD’s Top 10 Most Popular Stories for January 2024
Structural heart interventions were dominant on this month’s list, but so too were stories on a range of CVD medications.
January’s mix of stories include everything from the disappointment over Medicare reimbursement cuts in the United States to patients satisfied at being able to eat or drink right up to the time of their coronary interventions—as studied in a small, randomized trial. Several stories of structural heart interventions make the list, but so too did stories of direct oral anticoagulants and P2Y12 inhibitors. Standing out from the pack was a story addressing the steady rise in the number of sudden cardiac deaths due to substance abuse.
In what has become an annual source of frustration, efforts by professional groups failed to eliminate the planned 3.37% cut for physician reimbursement that went into effect earlier this month.
As a new study has documented, no demographic was immune to CV deaths tied to alcohol, opioids, and other drugs over the last two decades.
Proponents of eliminating on-site surgery during TAVI procedures say it will increase access. Others worry that doing so would cost patient lives.
This is the latest study to show that NPO before a cardiac catheterization is an outdated practice with no benefits.
The latest analysis compares patient outcomes before and after guidelines changed. Again, a simpler approach won out.
Off-label abuse is not limited to PFO closure, but the proportion of devices implanted without documented findings of the FDA-approved indication raises questions, say investigators.
There are scenarios where the agents may be harmful, and others where more evidence is urgently needed. A new document helps navigate these decisions.
A UK Biobank analysis confirms that LDL is more abundant and drives most ASCVD risk, but Lp(a) carries a powerful punch.
Rates of TAVI and SAVR, but not CABG, are disproportionately low in zip codes with a high area deprivation index.
A deep dive into a French study shows the benefits of mitral TEER were seen in older, sicker patients who were at high risk for surgery.